Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the company has initiated submission of a rolling New Drug Application (NDA) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE